| ||||||||||||||
|
|
|||||||||||||

Departments of *Anesthesiology and
Orthopedics and Rehabilitation, University of Florida College of Medicine, Gainesville, Florida
Address correspondence and reprint requests to F. Kayser Enneking, MD, Department of Anesthesiology, PO Box 100254, Gainesville, FL 32610-0254. Address e-mail to enneking{at}anest2 anest.ufl.edu.
| Abstract |
|---|
|
|
|---|
IMPLICATIONS: Portable pumps often used for local anesthetic infusion during continuous regional analgesia exhibit varying degrees of delivery rate accuracy and consistency. Furthermore, increases in temperature result in an increased infusion rate for various pumps investigated. These factors should be taken into consideration when choosing and using a portable infusion pump.
| Introduction |
|---|
|
|
|---|
We have had ambulatory patients using various portable pumps exhaust their local anesthetic reservoir after 50% to 150% of the expected infusion duration. This is consistent with the experience of other investigators (8). No apparent increase in anesthetic morbidity resulted from these highly variable infusion rates, yet the quality of analgesia lacked consistency, and infusion duration was unpredictable. We were concerned about possible local anesthetic toxicity in patients if infusion rates remained irregular. Many of these pumps regulate the infusion flow rate by using a temperature-dependent device calibrated to skin temperature. Therefore, we performed this laboratory study to define the flow rate accuracy, reliability, and profiles of various portable infusion pumps at expected and higher-than-expected temperatures.
| Methods |
|---|
|
|
|---|
|
|
|
Study Apparatus
To record the infusion rate profiles, the following apparatus was used (Fig. 2). The infusion pump was first attached to a polyamide multiport catheter (B. Braun Medical, Bethlehem, PA). For all pumps, with the exception of the Microject PCA, the flow rate regulator found near the connection between the pump tubing and catheter attachment was placed within an adjustable heating unit (Microplate Incubator; Boekel Scientific, Feasterville, PA). An empty plastic bottle with a removable plastic cap was used to collect the dispensed fluid. One hole in the plastic cap was made with a 19-gauge needle, and the distal end of the catheter was inserted through this hole into the collection bottle.
|
Although the scale manufacturer reports accuracy of ±0.1 g, we were concerned about time-related drift and possible infusate evaporation over the duration of these experiments. To test for potential evaporation loss and scale drift, 100 g of NS was placed in the collection bottle with the catheter in place for 2 wk. Measurements were taken each minute, and the loss to evaporation was <0.1 g (0.1%) over the testing period. Scale drift over the 2 wk was ±0.4 g (0.4%). The ambient room air temperature was held between 20°24°C (68°75°F) during the entire study period. A temperature-monitoring device (Hobo H8; Onset Computer Corp., Bourne, MA) recorded ambient temperature every 5 min during the entire study period to ensure a uniform room temperature for the infusion pumps. Based on these data, we conclude that the apparatus was appropriate to test pump performance over the duration of at least 60 h.
Each infusion pump was tested with the flow rate regulator placed in the heating unit. The temperature of the heating unit was set at the temperature that the manufacturer reported to be skin temperature (the baseline, or expected, temperature). For example, the Accufuser was calibrated by the manufacturer for a flow rate of 5.0 mL/h at 32°C, whereas the I-Flow was calibrated at 31°C. If a manufacturer-recommended temperature was not included with the infusion pump, then 31°C was used.
Each test was performed twice with a new infusion pump unit. If the infusion rate during the second trial differed more than ±10% of the original trial at any point, a third trial was performed. The trials were combined to produce a mean profile for each pump at the baseline (expected) temperature. After this, all pumps (except the Microject PCA) were tested again by using the same protocol, but with the heating unit set 4°C more than the baseline temperature. The Microject PCA infusion rate is controlled electronically and is relatively temperature independent over a small-scale temperature change (e.g., 4°C).
Infusion duration (measured) was considered to end when the measured flow rate decreased <50% of the set rate. Data were reported as mean ± SD. Overall comparisons were made by using analysis of variance on ranks with post hoc Tukey pairwise testing, if appropriate. P < 0.05 was considered to be statistically significant.
| Results |
|---|
|
|
|---|
|
Accuracy
At their "expected" operating temperature, the pumps infused at a rate within ±15% of their set rate to differing degrees (Table 3). The Microject PCA, Accufuser, and C-Bloc pumps infused within this range 100%, 90%, and 86% of their infusion duration, respectively. The MedFlo II, Sgarlato, and Pain Pumps infused within this range 70%, 57%, and 18% of their infusion duration, respectively.
|
Temperature Effects
Temperature markedly affected overall pump performance (P = 0.05). Increasing the temperature of the flow rate regulator 4°C affected each pump differently (Fig. 3). With the temperature change, the infusion rates of the MedFlo II and C-Bloc pumps increased between 10% and 33%. This increase in rate resulted in a decreased infusion duration of approximately 25% for each (Table 3). The Accufuser and Pain Pump infusion rates also increased with an increase in temperature, although they were <10%. The infusion rate of the Sgarlato pump was not consistently affected by a change in temperature.
| Discussion |
|---|
|
|
|---|
Implications
These differences in flow rate accuracy may have significant implications for patient care when applied to continuous regional analgesia. Although there is nothing inherently wrong with an infusion rate that varies over time as these pumps provide, health care providers must be aware of the infusion profile to maximize patient safety and benefit. There are potential advantages and disadvantages to all of the infusion profiles described in this study, and the pump profile must be adequately matched to the situation/indication. For example, because surgical pain generally decreases over time, a pump that provides a declining rate of infusion may be appropriate for an adult patient receiving a perineural local anesthetic infusion for postoperative analgesia. However, this profile may provide a subtherapeutic infusion rate during the latter portion of the infusion period, and, consequently, unsatisfactory analgesia. When choosing the proper infusion pump for a given application, several factors must be accounted for, including, but not limited to, acceptable flow rate accuracy, desired infusion duration, and total local anesthetic volume requirement.
For many of the pumps described in this investigation, temperature influenced the rate of infusion (Table 3, Fig. 3). For the C-Bloc and MedFlo II pumps, an increase of 4°C resulted in an increased flow rate of >10%, whereas the Accufuser and Pain Pump were affected to a lesser extent. Although the Sgarlato pump uses an infusion-regulating device similar in appearance and placement to these other pumps, the manufacturer states that it is temperature independent. This was confirmed in our investigation.
The degree to which the temperature sensitivity of a given pump should influence a decision regarding its use is highly situation dependent. For example, our institution is located in Florida where summer temperatures often reach 39°C, increasing skin and ambient temperature, which affects the flow regulators of various infusion pumps. After this study, we instructed our patients to remain in air-conditioned environments when using a temperature-sensitive infusion pump during the summer months. This investigation only varied temperature with an increase of 4°C. A larger increase should theoretically increase the flow rate more than reported here, whereas a temperature decrease should theoretically result in a flow rate decrease. However, this speculation is based on the physics of the flow regulator technology and requires additional investigation for confirmation.
Battery Charge
Another variable that may influence the infusion rate of electronic pumps is battery power. The continuous decline of the Microject PCAs infusion rate (a total of approximately 10%) throughout the entire 60-hour test duration may be evidence of this phenomenon. Information included with this pump states that the "battery life" using 2 AA alkaline 1.5-volt batteries is 10 days at a flow rate of 9.9 mL/h. If and when the batteries should be replaced during an infusion deserve further study.
Pump Choice
Although the electronic pump described in this investigation had the most accurate and consistent flow rate of the pumps studied, there are other factors that should be considered when choosing an optimal pump for a given indication. These include patient and health care provider convenience, reliability, cost, ease of use, as well as the clinical factors mentioned previously. For example, for an intraarticular local anesthetic infusion at a desired rate of 2 mL/h in an adult, it may be desirable to use one of the nonelectronic pumps for its simplicity and disposability. In this case, a change of 10%20% in the flow rate may not be clinically significant, and the other factors that will help determine the optimal device may outweigh infusion rate accuracy and consistency. Whereas it is beyond the scope of this discussion to comment on every variable, health care providers should take all of these into account when choosing an infusion pump for a specific circumstance.
Study Limitation
We included only the infusion rate regulators in the heating unit. This was to simulate average skin temperature for the regulating devices because these are usually taped to the patients skin, whereas the infusion pump itself is left at ambient room temperature. To simulate a temperature increase of the flow rate regulator, we increased the temperature of the heating device, but the ambient room temperature of the infusion pumps remained constant. Therefore, it is unknown what the effect of increasing the temperature for both the flow regulator and the pump would have on the flow rate (this includes the Microject PCA).
In conclusion, portable pumps often used for local anesthetic infusion during continuous regional analgesia exhibit varying degrees of delivery rate accuracy and consistency. Furthermore, increases in temperature result in an increased infusion rate of various degrees for many of the infusion pumps investigated. Healthcare providers should take these factors into consideration when choosing and using a portable infusion pump for local anesthetic administration. Controlled clinical studies are needed to investigate how local anesthetic infusion rate variability affects patient analgesia.
| Acknowledgments |
|---|
The authors thank Jenny Kline Ilfeld, MD, for her valuable editorial contributions.
| Footnotes |
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
D. Q.H. Tran, L. Munoz, G. Russo, and R. J. Finlayson Ultrasonography and stimulating perineural catheters for nerve blocks: a review of the evidence: [L'echographie et les catheters perineuraux stimulants pour les blocs nerveux : une synthese des donnees probantes] Can J Anesth, July 1, 2008; 55(7): 447 - 457. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. R. Cichocki JR., T. A. Barbolt, S. J. Savidge, G. Chen, and J. Zhou A Bioabsorbable Microcatheter for the Continuous and Direct Treatment of Surgical Sites J Biomater Appl, September 1, 2007; 22(2): 145 - 162. [Abstract] [PDF] |
||||
![]() |
E. A. Skryabina and T. S. Dunn Disposable infusion pumps. Am. J. Health Syst. Pharm., July 1, 2006; 63(13): 1260 - 1268. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Ilfeld and F. K. Enneking Continuous Peripheral Nerve Blocks at Home: A Review Anesth. Analg., June 1, 2005; 100(6): 1822 - 1833. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Ilfeld, T. E. Morey, X. Capdevila, C. Dadure, N. Bernard, S. Lopez, P. Macaire, and P. Aknin Use of Term "Patient-Controlled" May Be Confusing in Study of Elastometric Pump * Response Anesth. Analg., September 1, 2003; 97(3): 916 - 917. [Full Text] [PDF] |
||||
![]() |
M. Mizuuchi, M. Yamakage, S. Iwasaki, A. Kimura, and A. Namiki The infusion rate of most disposable, non-electric infusion pumps decreases under hypobaric conditions: [La vitesse de perfusion de la plupart des pompes a perfusion non electriques jetables diminue dans des conditions hypobares] Can J Anesth, August 1, 2003; 50(7): 657 - 662. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Ilfeld, T. E. Morey, T. W. Wright, L. K. Chidgey, and F. K. Enneking Continuous Interscalene Brachial Plexus Block for Postoperative Pain Control at Home: A Randomized, Double-Blinded, Placebo-Controlled Study Anesth. Analg., April 1, 2003; 96(4): 1089 - 1095. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|